Assembly Biosciences Inc (NASDAQ:ASMB) had an increase of 12.23% in short interest. ASMB’s SI was 399,200 shares in April as released by FINRA. Its up 12.23% from 355,700 shares previously. With 236,500 avg volume, 2 days are for Assembly Biosciences Inc (NASDAQ:ASMB)’s short sellers to cover ASMB’s short positions. The SI to Assembly Biosciences Inc’s float is 3.16%. The stock decreased 5.97% or $2.79 during the last trading session, reaching $43.96. About 77,053 shares traded. Assembly Biosciences, Inc. (NASDAQ:ASMB) has risen 110.93% since April 23, 2017 and is uptrending. It has outperformed by 99.38% the S&P500.
The stock of UBS Group AG (NYSE:UBS) is a huge mover today! The stock decreased 3.00% or $0.53 during the last trading session, reaching $17.12. About 1.85M shares traded. UBS Group AG (NYSE:UBS) has risen 10.64% since April 23, 2017 and is uptrending. It has underperformed by 0.91% the S&P500.The move comes after 9 months negative chart setup for the $64.68B company. It was reported on Apr, 23 by Barchart.com. We have $16.26 PT which if reached, will make NYSE:UBS worth $3.23B less.
Among 12 analysts covering UBS AG (NYSE:UBS), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. UBS AG had 21 analyst reports since September 15, 2015 according to SRatingsIntel. On Tuesday, June 28 the stock rating was downgraded by RBC Capital Markets to “Underperform”. JP Morgan downgraded the shares of UBS in report on Wednesday, October 28 to “Neutral” rating. On Tuesday, February 7 the stock rating was upgraded by Bank of America to “Neutral”. As per Tuesday, November 3, the company rating was downgraded by Bank of America. The stock has “Hold” rating by Kepler Cheuvreux on Tuesday, February 9. The firm has “Underweight” rating by JP Morgan given on Monday, June 27. The rating was upgraded by Keefe Bruyette & Woods to “Outperform” on Thursday, November 10. JP Morgan upgraded UBS Group AG (NYSE:UBS) on Monday, June 26 to “Overweight” rating. Bank of America upgraded UBS Group AG (NYSE:UBS) on Wednesday, October 7 to “Buy” rating. Macquarie Research downgraded the stock to “Neutral” rating in Wednesday, February 24 report.
UBS Group AG, together with its subsidiaries, provides financial advice and solutions clients worldwide. The company has market cap of $64.68 billion. It operates through five divisions: Wealth Management, Wealth Management Americas, Personal & Corporate Banking, Asset Management, and Investment Bank. It has a 60.71 P/E ratio. The Wealth Management division offers advisory and financial services to wealthy private clients.